Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats

Reproduction

Volumn 143, Issue 1, 2012, Pages 21-33

  Tyndall, Victoria ^a,b   Broyde, Marie ^a   Sharpe, Richard ^a,c   Welsh, Michelle ^a,d   Drake, Amanda J ^a   McNeilly, Alan S ^a,c  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MUELLERIAN INHIBITING FACTOR; TESTOSTERONE PROPIONATE;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOVULATION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FETUS; HORMONE DETERMINATION; HORMONE SYNTHESIS; MORPHOMETRICS; NEWBORN; NONHUMAN; OOCYTE; OVARY FOLLICLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PRENATAL EXPOSURE; PREPUBERTY; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE; UTERUS WEIGHT;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; DISEASE MODELS, ANIMAL; FEMALE; FETUS; HUMANS; OVARY; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, WISTAR; TESTOSTERONE PROPIONATE; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 84855651240     PISSN: 14701626     EISSN: 17417899     Source Type: Journal    
DOI: 10.1530/REP-11-0239     Document Type: Article

References (77)

1. Abbott DH, Dumesic DA, Eisner JR, Colman RJ & Kemnitz JW 1998 Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys. Trends in Endocrinology and Metabolism 9 62-67. (doi:10.1016/S1043-2760(98)00019-8)
2. Abbott DH, Dumesic DA & Franks S 2002 Developmental origin of polycystic ovary syndrome - a hypothesis. Journal of Endocrinology 174 1-5. (doi:10.1677/joe.0.1740001)
3. Abbott DH, Dumesic DA, Levine JE, Dunaif A & Padmanabhamn V 2007 Animal models and fetal programming of the polycystic ovary syndrome. In Contemporary Endocrinology: Androgen Excess Disorders in Women, IV, pp 259-272. Ed. R Azziz. Totawa, NJ: Humana Press.
4. Abbott DH, Tarantal AF & Dumesic DA 2009 Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. American Journal of Primatology 71 776-784. (doi:10.1002/ajp.20679)
5. Alexanderson C, Eriksson E, Stener-Victorin E, Lystig T, Gabrielsson B, Lonn M & Holmang A 2007 Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone. Endocrinology 148 5369-5376. (doi:10.1210/en.2007-0305)
6. Anderiesz C & Trounson AO 1995 The effect of testosterone on the maturation and developmental capacity of murine oocytes in vitro. Human Reproduction 10 2377-2381.
7. Anderson E & Lee GY 1997 The polycystic ovarian (PCO) condition: apoptosis and epithelialization of the ovarian antral follicles are aspects of cystogenesis in the dehydroepiandrosterone (DHEA)-treated rat model. Tissue & Cell 29 171-189. (doi:10.1016/S0040-8166(97)80017-1)
8. Anderson E, Lee GY & O'Brien K 1997 Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles. Anatomical Record 249 44-53. (doi:10.1002/(SICI)1097- 0185(199709)249:1〈44::AID-AR6〉3.0.CO;2-F)
9. Baravalle C, Salvetti NR, Mira GA, Lorente JA & Ortega HH 2007 The role of ACTH in the pathogenesis of polycystic ovarian syndrome in rats: hormonal profiles and ovarian morphology. Physiological Research 56 67-78.
10. Barraclough CA 1961 Production of anovulatory, sterile rats by single injections of testosterone propionate. Endocrinology 68 62-67. (doi:10.1210/endo-68-1-62)
11. Beloosesky R, Gold R & Almog B 2004 Induction of polycystic ovary by testosterone in immature female rats: modulation of apoptosis and attenuation of glucose/insulin ratio. International Journal of Molecular Medicine 14 207-215.
12. Billig H, Furuta I & Hsueh AJ 2003 Oestrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology 133 2204-2212. (doi:10.1210/en.133.5.2204)
13. Brawer JR, Naftolin F, Martin J & Sonnenschein C 1978 Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology 103 501-512. (doi:10.1210/endo-103-2-501)
14. Brawer JR, Munoz M & Farookhi R 1986 Development of the polycystic ovarian condition (PCO) in the estradiol valerate-treated rat. Biology of Reproduction 35 647-655. (doi:10.1095/biolreprod35.3.647)
15. Carretero J, Vázquez G, Rubio M, Blanco E, Juanes JA, Pérez E, Burks D & Vázquez R 2003 Postnatal differentiation of the immunohistochemical expression of aromatase P450 in the rat pituitary gland. Histology and Histopathology 18 419-423. (Pubitemid 36362059)
16. Champagne FA, Francis DD, Mar A & Meaney MJ 2003 Variations in maternal care in the rat as a mediating influence for the effects of environment on development. Physiology & Behavior 79 359-371. (doi:10.1016/S0031- 9384(03)00149-5)
17. Chen Y, Breen K & Pepling ME 2009 Estrogen can signal through multiple pathways to regulate oocyte cyst breakdown and primordial follicle assembly in the neonatal mouse ovary. Journal of Endocrinology 202 407-417. (doi:10.1677/JOE-09-0109)
18. Childs A, Kinnell HL, Collins CS, Hogg K, Bayne RAL, Green SJ, McNeilly AS & Anderson RA 2010 BMP signaling in the human fetal ovary is developmentally regulated and promotes primordial germ cell apoptosis. Stem Cells 28 1368-1378. (doi:10.1002/stem.440)
19. Cottrell EC & Seckl JR 2009 Prenatal stress, glucocorticoids and the programming of adult disease. Frontiers in Behavioral Neuroscience 3 1-9. (doi:10.3389/neuro.08.019.2009)
20. Drummond AE 2006 The role of steroids in follicular growth. Reproductive Biology and Endocrinology 4 16-26. (doi:10.1186/1477-7827-4-16)
21. Durlinger ALL, Visser VA & Themmen APN 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124 601-609. (doi:10.1530/rep.0.1240601)
22. Faiman C, Reyes FI, Dent DW, Fuler GB, Hobson WC & Thliveris JA 1988 Effects of long-term testosterone exposure on ovarian function and morphology in the rhesus monkey. Anatomical Record 222 245-251. (doi:10.1002/ar.1092220305)
23. Franks S 2009 Do animal models of polycystic ovary syndrome help to understand its pathogenesis and management? Yes, but their limitations should be recognized Endocrinology 150 3983-3985. (doi:10.1210/en.2009-0652)
24. Franks S, McCarthy MI & Hardy K 2006 Development of polycystic ovary syndrome: involvement of genetic and environmental factors. International Journal of Andrology 28 278-285. (doi:10.1111/j.1365-2605.2005.00623.x)
25. Fulghesu AM, Angioni S, Frau E, Belosi C, Apa R, Mioni R, Xamin N, Capobianco GP, Dessole S, Fruzzetti F et al. 2007 Ultrasound in polycystic ovary syndrome - the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study. Human Reproduction 22 2501-2508. (doi:10.1093/humrep/dem202)
26. Grossmann R, Diez-Guerra FJ, Mansfield S & Dyer RG 1987 Neonatal testosterone modifies LH secretion in the adult female rat by altering the opioid-noradrenergic interaction in the medial preoptic area. Brain Research 415 205-210. (doi:10.1016/0006-8993(87)90202-2)
27. Hillier SG & Tetsuka M 1997 Role of androgens in follicle maturation and atresia. Baillière's Clinical Obstetrics and Gynaecology 11 249-260. (doi:10.1016/S0950-3552(97)80036-3)
28. Hirshfield AN & Midgley AR Jr 1978 Morphometric analysis of follicular development in the rat. Biology of Reproduction 19 597-605. (doi:10.1095/biolreprod19.3.597)
29. Hoepfner BA & Ward IL 1988 Prenatal and neonatal androgen exposure interact to affect sexual differentiation in female rats. Behavioral Neuroscience 102 61-65. (doi:10.1037/0735-7044.102.1.61)
30. Hogg K, McNeilly AS & Duncan WC 2011 Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology 152 2048-2059. (doi:10.1210/en.2010-1219)
31. Honnma H, Endo T, Henmi H, Nagasawa K, Baba T, Yamazaki K, Kitajima Y, Hayashi T, Manase M & Saito T 2006 Altered expression of Fas/Fas ligand/caspase 8 and membrane type 1-matrix metalloproteinase in atretic follicles within dehydroepiandrosterone-induced polycystic ovaries in rats. Apoptosis 11 1525-1533. (doi:10.1007/s10495-006-9148-2)
32. Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY & Chang C 2004 Subfertility and defective folliculogenesis in female mice lacking androgen receptor. PNAS 101 11209-11214. (doi:10.1073/pnas.0404372101)
33. Jefferson W, Newbold R, Padilla-Banks E & Pepling M 2006 Neonatal genistein treatment alters ovarian differentiation in the mouse: inhibition of oocyte nest breakdown and increased oocyte survival. Biology of Reproduction 74 161-168. (doi:10.1095/biolreprod.105.045724)
34. Kezele P & Skinner MK 2003 Regulation of ovarian primordial follicle assembly and development by estrogen and progesterone: endocrine model of follicle assembly. Endocrinology 144 3329-3337. (doi:10.1210/en.2002-0131)
35. Levallet J, Pirjo Pakarinen P & Huhtaniemi IT 1999 Follicle-stimulating hormone ligand and receptor mutations, and gonadal dysfunction. Archives of Medical Research 30 486-494. (doi:10.1016/S0188- 0128(99)00058-5)
36. Mahesh VB, Mills TM, Bagnell CA & Conway BA 1987 Animal models for study of polycystic ovaries and ovarian atresia. In Regulation of Ovarian and Testicular Function, 198, pp 237-257. Eds VB Mahesh, DS Dhinsa, E Anderson & SP Katra. New York: Plenum Press.
37. Manneras L, Cajander S, Holmäng A, Seleskovic M, Lystig T, Lönn M & Stener-Victorin E 2007 A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148 3781-3791. (doi:10.1210/en.2007-0168)
38. Manneras L, Jonsdottir IH, Holmäng A, Lönn M & Stener-Victorin E 2008 Low frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome. Endocrinology 149 3559-3568. (doi:10.1210/en.2008-0053)
39. McNatty KP, Quirke LD, Fidler A, Smith P, Heath DA & Tisdall D 2000 Ovarian development: fetus to puberty. In Hormones and Women's Health, pp 9-22. Ed. LA Salamonsen. Australia: Harwood Academic Publishers.
40. McNeilly JR, Saunders PTK, Taggart M, Cooke HJ & McNeilly AS 2000 Loss of oocytes in Dazl knockout mice results in maintained ovarian steroidogenic function but altered gonadotropin secretion in adult animals. Endocrinology 141 4284-4294. (doi:10.1210/en.141.11.4284)
41. McNeilly AS, Crawford JL, Taragnat C, Nicol L & McNeilly JR 2003 The differential secretion of FSH and LH: regulation through genes, feedback and packaging. Reproduction Supplement 61 463-476.
42. McNeilly JR, Watson E, Brown Y, Murray AA, Spears N & McNeilly AS 2011 Decreased oocyte DAZL expression results in increased litter size by modulating FSH-induced follicle growth. Biology of Reproduction 85 584-593. (doi:10.1095/biolreprod.110.086264)
43. Misugi T, Ozaki K, El Beltagy K, Tokuyama O, Honda K & Ishiko O 2006 Insulin-lowering agents inhibit synthesis of testosterone in ovaries of DHEA-induced PCOS rats. Gynecologic and Obstetric Investigation 61 208-215. (doi:10.1159/000091496)
44. Murray AA, Gosden RG, Allison V & Spears N 1998a Effects of androgens on the development of mouse follicles growing in vitro. Journal of Reproduction and Fertility 113 27-33. (doi:10.1530/jrf.0.1130027)
45. Murray AA, Swales AKE, Smith RE, Molinek MD, Hillier SG & Spears N 1998b Follicular growth and oocyte competence in the in vitro cultured mouse follicle: effects of gonadotrophins and steroids. MHR-Basic Science of Reproductive Medicine 14 75-83.
46. Nelson VL, Legro RS, Strauss JF III & McAllister JM 1999 Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. Molecular Endocrinology 13 946-957. (doi:10.1210/me.13.6.946)
47. Nelson VL, Qin K, Rosenfeldt RL, Wood JR, Penning TM, Legro RS, Strauss JF III & McAllister JM 2001 The biochemical basis for increased testosterone production in theca cells propogated from patients with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 86 5925-5933. (doi:10.1210/jc.86.12.5925)
48. Nilsson C, Niklasson M, Eriksson E, Bjorntorp P & Holmang A 1998 Imprinting of female offspring with testosterone results in insulin resistance and changes in body fat distribution at adult age in rats. Journal of Clinical Investigation 101 74-78. (doi:10.1172/JCI1353)
49. Ota H, Wakizaka A, Fukushima M & Maki M 1986 Enhanced ovarian gonadotropin receptors in the testosterone-induced polycystic ovary in rats. Tohoku Journal of Experimental Medicine 148 313-325. (doi:10.1620/tjem.148.313)
50. Pellatt L, Rice S & Mason HD 2010 Anti-Mullerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 139 825-833. (doi:10.1530/REP-09-0415)
51. Pepling ME 2006 From primordial germ cell to primordial follicle: mammalian female germ cell development. Genesis 44 622-632. (doi:10.1002/dvg. 20258)
52. Pepling ME & Spradling AC 2001 Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Developmental Biology 234 339-351. (doi:10.1006/dbio.2001.0269)
53. Picon R, Pelloux MC, Benhaim A & Gloaguen F 1985 Conversion of androgen to estrogen by rat fetal and neonatal female gonad: effects of dbCAMP and FSH. Journal of Steroid Biochemistry 23 995-1000. (doi:10.1016/0022-4731(85) 90058-5)
54. Qureshi AI, Nussey SS, Bano G, Musonda P, Whitehead SA & Mason HD 2008 Testosterone selectively increases primary follicles in ovarian cortex grafted onto embryonic chick membranes: relevance to polycystic ovaries. Reproduction 136 187-194. (doi:10.1530/REP-07-0172)
55. Rey R, Lukas-Croisier C, Lasala C & Bedecarrás P 2003 AMH/MIS: what we know already about the gene, the protein and its regulation. Molecular and Cellular Endocrinology 211 21-31. (doi:10.1016/j.mce.2003.09.007)
56. Roland AV, Nunemaker CS, Keller SR & Moenter SM 2010 Prenatal androgen exposure programs metabolic dysfunction in female mice. Journal of Endocrinology 207 213-223. (doi:10.1677/JOE-10-0217)
57. Roma PG, Huntsberry ME & Riley AL 2007 Separation stress, litter size, and the rewarding effects of low-dose morphine in the dams of maternally separated rats. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 429-433. (doi:10.1016/j.pnpbp.2006.11.005)
58. Rosa ESA, Guimaraes MA, Padmanabhan V & Lara HE 2003 Prepubertal administration of estradiol valerate disrupts cyclicity and leads to cystic ovarian morphology during adult life in the rat: role of sympathetic innervation. Endocrinology 144 4289-4297. (doi:10.1210/en.2003-0146)
59. Rossetti R, Pasquale ED, Marozzi A, Bione S, Toniolo D, Grammatico P, Nelson LM, Beck-Peccoz P & Persani L 2009 BMP15 mutations associated with primary ovarian insufficiency cause a defective production of bioactive protein. Human Mutation 30 804-810. (doi:10.1002/humu.20961)
60. Scalzo CM & Michael SD 1988 Source of high testosterone levels associated with autoimmune ovarian dysgenesis in neonatally thymectomized B6A mice. Biology of Reproduction 38 1115-1121. (doi:10.1095/biolreprod38.5.1115)
61. Schindler R, Nilsson E & Skinner MK 2010 Induction of ovarian primordial follicle assembly by connective tissue growth factor CTGF. PLoS ONE 5 e12979. (doi:10.1371/journal.pone.0012979)
62. Sen A & Hammes SR 2010 Granulosa cell-specific androgen receptors are critical regulators of ovarian development and function. Molecular Endocrinology 24 1393-1403. (doi:10.1210/me.2010-0006)
63. Shiina H, Matsumoto T, Sato T, Igarishi K, Miyamoto J, Takemasa S, Sakari M, Takada I, Nakamura T, Metzger D et al. 2006 Premature ovarian failure in androgen receptor-deficient mice. PNAS 103 224-229. (doi:10.1073/pnas. 0506736102)
64. Slob AK, den Hamer R, Woutersen PJ & van der Werff ten Bosch JJ 1983 Prenatal testosterone propionate and postnatal ovarian activity in the rat. Acta Endocrinologica 103 420-427.
65. Steckler T, Manikkam M, Inskeep EK & Padmanabhan V 2007 Developmental programming: follicular persistence in prenatal testosteronetreated sheep is not programmed by androgenic actions of testosterone. Endocrinology 148 3532-3540. (doi:10.1210/en.2007-0339)
66. Steckler TL, Herkimer C, Dumesic DA & Padmanabhan V 2009 Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity - implication for polycystic ovary syndrome. Endocrinology 150 1456-1465. (doi:10.1210/en.2008-1256)
67. Tetsuka M, Whitelaw PF, Bremner WJ, Millar MR, Smyth CD & Hillier SG 1995 Developmental regulation of androgen receptor in rat ovary. Journal of Endocrinology 145 535-543. (doi:10.1677/joe.0.1450535)
68. Walters KA, Allan CM & Handelsman DJ 2008 Androgen action and the ovary. Biology of Reproduction 78 380-389. (doi:10.1095/biolreprod.107.064089)
69. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K & Franks S 2003 Formation and early development of follicles in the polycystic ovary. Lancet 362 1017-1021. (doi:10.1016/S0140-6736(03)14410-8)
70. Welsh M, Saunders PTK, Fisken M, Scott HM, Hutchison GR, Smith LB, Richard M & Sharpe RM 2008 Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. Journal of Clinical Investigation 118 1479-1490. (doi:10.1172/JCI34241)
71. Welsh M, MacLeod DJ, Walker M, Smith LB & Sharpe RM 2010 Critical androgen-sensitive periods of rat penis and clitoris development. International Journal of Andrology 33 e144-e152. (doi:10.1111/j.1365-2605.2009.00978.x)
72. Welt CK, Taylor AE, Fox J, Messerlian GM, Adams JM & Schneyer AL 2005 Follicular arrest in polycystic ovary syndrome is associated with deficient inhibin A and B biosynthesis. Journal of Clinical Endocrinology and Metabolism 90 5582-5587. (doi:10.1210/jc.2005-0695)
73. Wolf CJ, Ostby JS, LeBlanc GA & Gray LE Jr 2002 Effects of prenatal testosterone propionate on the sexual development of male and female rats: a dose-response study. Toxicological Science 65 71-86. (doi:10.1093/toxsci/65.1. 71)
74. Wolf CJ, LeBlanc GA & Gray LE Jr 2004 Interactive effects of vinclozolin and testosterone propionate on pregnancy and sexual differentiation of the male and female SD rat. Toxicological Science 78 135-143. (doi:10.1093/toxsci/kfh018)
75. Xia P & Younglai EV 2000 Relationship between steroid concentrations in ovarian follicular fluid and oocyte morphology in patients undergoing intracytoplasmic sperm injection (ICSI) treatment. Journal of Reproduction and Fertility 118 229-233. (doi:10.1530/reprod/118.2.229)
76. Yan C, Wang P, DeMayo J, DeMayo FJ, Elvin JA, Carino C, Prasad SV, Skinner SS, Dunbar BS, Dube JL et al. 2001 Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Molecular Endocrinology 15 854-866. (doi:10.1210/me.15.6.854)
77. Young J & McNeilly AS 2010 Theca - the forgotten cell of the ovarian follicle. Reproduction 140 489-504. (doi:10.1530/REP-10-0094)